Providing expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia.
Welcome to Lucid Health Consulting
With over 30 years of Health Economics, Pricing & Reimbursement, Strategic Market Access and Health Technology Assessment experience, we have helped many organisations navigate the complexities of the Australian regulatory environment and achieve market access.
We have a proven track record of enabling companies and organisations to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.
Let us show you how our strategic approach and team experience can help you achieve market access in Australia.
How we can help your business?
Read our articles, find out about our upcoming webinars and speaking engagements for the latest industry insights.
ISPOR 2023 Boston, MA, USA, 7-10 May
Registration is now open for the ISPOR 2023 Conference, May 7 – 10 in Boston, MA, USA. This conference is the leading international conference for health economics and outcomes research (HEOR) and is a must-attend event providing dedicated opportunities to network...
ISPOR Europe 2022, 6 – 9 November with Poster
The ISPOR Europe 2022 Global Conference for Health Economics and Outcomes Research (HEOR) was held this year on 6-9 November, in-person in Vienna and virtually for discussion and dissemination of the latest trends in healthcare. This year’s conference theme was:...
8th Annual Drugs & Devices Australia Webinar – Reimbursement Update 2022
Free Webinar: 8th Annual Drugs & Devices Australia – Reimbursement Update Please join us for this free webinar, hosted by George Papadopoulos, Partner & Director of Lucid Health Consulting and Sarah Griffin, Director of MedTechnique Consulting as they discuss...
What our clients are saying.
The Lucid team’s thoughtful consideration of the strategic direction of a submission, their expert economic modelling skills and their ability to draw out the narrative of the value proposition ensures that the overall cost-effectiveness outcome is compelling to technical evaluators and general payers alike.
Lucid Heath Consulting are excellent to work with. All of their work is both scientifically rigorous and clearly articulated. Our very complex case was presented to us in a compelling way. The Directors at Lucid Health Consulting, have a great hands on approach and good direct dialogue with the relevant people in our organisation. We enjoyed working with Lucid Health Consulting and would recommend them and use them ourselves for our future projects.
Executive Director Integrated Market Access,
Lucid Health Consulting are providers of expert advice in health economics, pricing & reimbursement, market access and regulatory affairs in Australia. Enabling companies to optimise the entry of their pharmaceutical, biotech and medical devices into the Australian market.
32 Mitchell St, McMahon's Pt NSW 2060